Terazosin 68788-8171
Product NDC
68788-8171- Manufacturer
- Preferred Pharmaceuticals Inc.
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 25, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA075614
Need to source Terazosin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Terazosin Hydrochloride | 2 mg/1 |
Drug Class
Adrenergic alpha-Antagonists [MoA]alpha-Adrenergic Blocker [EPC]
Packaging Options(1)
30 CAPSULE in 1 BOTTLE (68788-8171-3)